<PAGE> 1
FORM 10-Q/A
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
{X} QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 1996
OR
{ } TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the Transition period from to
-------- --------
Commission file number 0-15846
-------
HealthCare COMPARE Corp.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 36-3307583
- ------------------------------- ---------------------------------------
(State or other jurisdiction of (I.R.S. Employer Identification Number)
incorporation or organization)
3200 Highland Avenue, Downers Grove, Illinois 60515
---------------------------------------------------
(Address of principal executive offices, Zip Code)
(708) 241-7900
------------------------------------------------
(Registrant's phone number, including area code)
----------------------------------------------------
(Former name, former address and former fiscal year,
if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.
Yes X No
----- -----
Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.
The number of shares of Common Stock, par value $.01 per share, outstanding on
May 8, 1996 was 34,962,385.
<PAGE> 2
PART II
Item 6. Exhibits and Reports on Form 8-K
(a) Exhibit 11 - Computation of Primary Earnings Per Common Share
(b) Exhibit 11 - Computation of Fully Diluted Earnings Per Common
Share
11
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
HealthCare COMPARE Corp.
Dated: May 10, 1996 /s/James C. Smith
---------------------------------------
James C. Smith
President and Chief Executive Officer
Dated: May 10, 1996 /s/Joseph E. Whitters
---------------------------------------
Joseph E. Whitters
Chief Financial Officer
(Principal Financial and Accounting
Officer)
12
<PAGE> 1
HEALTHCARE COMPARE CORP. AND SUBSIDIARIES EXHIBIT 11
COMPUTATION OF PRIMARY EARNINGS PER COMMON SHARE
(UNAUDITED)
<TABLE>
<CAPTION>
Three Months Ended March 31,
------------------------------------
1996 1995
----------- ----------
<S> <C> <C>
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . $18,950,000 $14,773,000
=========== ===========
Weighted average number of common shares
outstanding:
Shares outstanding from beginning of period . . . . . . . . 34,635,000 34,034,000
Other issuances of common stock . . . . . . . . . . . . . . 258,000 148,000
Purchases of treasury stock . . . . . . . . . . . . . . . . (73,000) (48,000)
Common Stock Equivalents:
Additional equivalent shares issuable from
assumed exercise of common stock options . . . . . . . . . 825,000 872,000
----------- -----------
Weighted average common and common share
equivalents . . . . . . . . . . . . . . . . . . . . . . . . . . 35,645,000 35,006,000
=========== ===========
Net income per common share . . . . . . . . . . . . . . . . . . . $ .53 $ .42
=========== ===========
</TABLE>
13
<PAGE> 2
HEALTHCARE COMPARE CORP. AND SUBSIDIARIES EXHIBIT 11
COMPUTATION OF FULLY DILUTED EARNINGS PER COMMON SHARE
(UNAUDITED)
<TABLE>
<CAPTION>
Three Months Ended March 31,
------------------------------------
1996 1995
----------- ----------
<S> <C> <C>
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . $18,950,000 $14,773,000
=========== ===========
Weighted average number of common shares
outstanding:
Shares outstanding from beginning of period . . . . . . . . 34,635,000 34,034,000
Other issuances of common stock . . . . . . . . . . . . . . 258,000 148,000
Purchases of treasury stock . . . . . . . . . . . . . . . . (73,000) (48,000)
Common Stock Equivalents:
Additional equivalent shares issuable from
assumed exercise of common stock options . . . . . . . . . 888,000 902,000
----------- -----------
Weighted average common and common share
equivalents . . . . . . . . . . . . . . . . . . . . . . . . . . 35,708,000 35,036,000
=========== ===========
Net income per common share . . . . . . . . . . . . . . . . . . . $ .53 $ .42
=========== ===========
</TABLE>
14
